Human EIF4A2 activation kit by CRISPRa

CAT#: GA101367

EIF4A2 CRISPRa kit - CRISPR gene activation of human eukaryotic translation initiation factor 4A2



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
EIF4A2 rabbit polyclonal antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


EIF4A2 (Myc-DDK-tagged)-Human eukaryotic translation initiation factor 4A2 (EIF4A2)
    • 10 ug

CNY 3,656.00
CNY 3,990.00


EIF4A2 Rabbit polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol EIF4A2
Locus ID 1974
Kit Components

GA101367G1, EIF4A2 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA101367G2, EIF4A2 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA101367G3, EIF4A2 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001967
Synonyms BM-010; DDX2B; eIF-4A-II; EIF4A; eIF4A-II; EIF4F
Summary ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon.[UniProtKB/Swiss-Prot Function]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...